Clinical Trials Directory

Trials / Completed

CompletedNCT03847792

Analgesic Effect Of Intra-articular Bupivacaine Fentanyl for Postoperative Pain Relief in Knee Arthroscopic Surgery

Analgesic Effect Of Intra-articular Dexamethasone Versus Fentanyl Added as an Adjuvant to Bupivacaine for Postoperative Pain Relief in Knee Arthroscopic Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
87 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

However, local anesthetic agents can produce analgesia for a limited time when used as a single injection. Bupivacaine is a local anesthetic that has an immediate action on pain by blocking peripheral afferents. However, as the ideal analgesic, the drug must cover the whole postoperative period (≥ 24 hours); therefore, bupivacaine is usually combined with many adjutants to provide long-lasting post-arthroscopy analgesia.

Detailed description

Intr-articular drug administration has gained popularity because of its simplicity and efficacy in achieving anesthesia for diagnostic and operative arthroscopy and for providing postoperative analgesia .although the knee joint has been examined most commonly, arthroscopy of other joints such as shoulder, ankle, wrist, metatarsophalangeal and temporomandibular joints is being increasingly used. Intra-articular installation of local anesthesia during arthroscopic procedures has been used by many orthopedic surgeons to provide pain relief after surgery.The aim of this study was to evaluate the analgesic efficacy of intra-articular dexamethasone versus fentanyl added as an adjuvant to bupivacaine in patients undergoing knee arthroscopic surgery

Conditions

Interventions

TypeNameDescription
DRUGGroup DB/Dexamethasone-BupivacaineThe patient were received an intra-articular injection of 18ml bupivacaine 0.25% added to 8mg dexamethasone.
DRUGGroup FB /Fentanyl-BupivacaineThe patient were received an intra-articular injection of 1 ug/kg fentanyl added to 18ml of 0.25% bupivacaine.
DRUGGroup PB/Placebo-BupivacainePatients were received an intra-articular injection of 2ml isotonic saline added to 18ml of 0.25% bupivacaine.

Timeline

Start date
2019-03-31
Primary completion
2020-05-30
Completion
2020-06-30
First posted
2019-02-20
Last updated
2020-09-11

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03847792. Inclusion in this directory is not an endorsement.